Michael Lee
Hematology & Oncology · Houston, TXNPI 1952539108
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by F. Hoffmann-la Roche AG at 47.6% of the total. Reporting peaked in 2019 at $24,995 and has fallen 92.4% since, to $1,888 in 2023.
Across 45 payments — averaging $794.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$17K
- Genentech, Inc.$8K
- G1 Therapeutics, Inc.$3K
- Array Biopharma Inc$3K
- Bayer$2K
- Janssen Research & Development, LLC$1K
- plus $2K from 8 others
Across 113 payments — averaging $28,794 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$1.8M
- EMD Serono, Inc.$524K
- Pfizer$500K
- Merck$254K
- Genentech, Inc.$117K
- Exelixis Inc.$73K
- plus $36K from 3 others
What the payments were for
- Consulting fees$10,04428%
- Speaking & faculty fees$10,27329%
- Travel & lodging$13,40537%
- Food & beverage$2,0366%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 13 | $17,006 |
| Genentech, Inc. | 5 | $7,681 |
| G1 Therapeutics, Inc. | 5 | $3,225 |
| Array Biopharma Inc | 1 | $2,520 |
| Bayer | 5 | $1,853 |
| Janssen Research & Development, LLC | 3 | $1,486 |
| Trisalus Life Sciences, Inc. | 5 | $688 |
| Eisai Inc. | 1 | $675 |
| Genentech USA, Inc. | 2 | $252 |
| Astrazeneca AB | 1 | $135 |
| Incyte Corporation | 1 | $93 |
| Merz Pharmaceuticals, LLC | 1 | $61 |
| Pfizer | 1 | $56 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,758 in reported general payments places this provider in the 85th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in Houston
- Devesh PandyaHouston$1.8M
- Elias JabbourHouston$1.3M
- Naval DaverHouston$853K
- Jorge Cortes-FrancoHouston$627K
- Courtney DinardoHouston$478K
- Prithviraj BoseHouston$463K
- Milind JavleHouston$326K
- Loretta NastoupilHouston$309K
- Boyu HuHouston$281K
- Luis CamachoHouston$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.